Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects With Crohn's Disease

NCT02914600 is registered in ClinicalTrials.gov with Lakefront Biotherapeutics NV as lead sponsor.

NCT NCT02914600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02914600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects With Crohn's Disease
Lead sponsor
Lakefront Biotherapeutics NV
Phase
Phase 3
Overall status
Terminated
Start date
March 17, 2017
Completion date
August 1, 2023
Enrollment
1,188 (actual)
Sites
486

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease